Systemic lidocaine for neuropathic pain relief

Pain

Volumn 87, Issue 1, 2000, Pages 7-17

  Mao, Jianren ^a   Chen, Lucy L ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Beth Deaconess Medical Center   (United States)

Author keywords

Ectopic discharge; Lidocaine; Mexiletine; Neuropathic pain; Sodium channel

Indexed keywords

BUPIVACAINE; LIDOCAINE; MEXILETINE; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN;

ALLODYNIA; CHRONIC PAIN; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERALGESIA; NERVE CONDUCTION; NERVE INJURY; NERVE POTENTIAL; NEURALGIA; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SIDE EFFECT;

ADMINISTRATION, ORAL; ANALGESICS; ANIMALS; HUMANS; LIDOCAINE; MEXILETINE; NEURALGIA; SODIUM CHANNEL BLOCKERS;

EID: 0034237501     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(00)00229-3     Document Type: Review

References (65)

1. Abdi S., Lee D.H., Chung J.M. The anti-allodynic effects of amytriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain. Anesth Analg. 87:1998;1360-1366.
2. Akopian A.N., Sivilotti L., Wood J.N. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature. 379:1996;257-262.
3. Akopian A.N., Souslova V., England S., Okuse K., Ogata N., Ure J., Smith A., Kerr B.J., McMahon S.B., Boyce S., Hill R., Stanfa L., Dickenson A.H., Wood J.N. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci. 2:1999;541-548.
4. Awerbuch G.I., Sandyk R. Mexiletine for thalamic pain syndrome. Int J Neurosci. 55:1990;129-133.
5. Bartlett E.E., Hutaserani O. Xylocaine for the relief of postoperative pain. Anesth Analg. 40:1961;296-304.
6. Bath F.W., Jensen T.S., Kastrup J., Stigsby B., Dejgard A. The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy. Pain. 40:1990;29-34.
7. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
8. Boas R.A., Covino B.G., Shahnarian A. Analgesic responses to I.V. lidocaine. Br J Anesth. 54:1982;501-505.
9. Brose W., Cousins M.J. Subcutaneous lidocaine for treatment of neuropathic cancer pain. Pain. 45:1991;145-148.
10. Calissi P.T., Jaber L.A. Peripheral diabetic neuropathy: current concepts in treatment. Ann Pharmacol. 29:1995;769-776.
11. Cassuto J., Wallin G., Hogstrom S., Faxen A., Ricmback G. Inhibition of postoperative pain by continuous low-dose intravenous infusion of lidocaine. Anesth Analg. 64:1985;971-974.
12. Chabal C., Russell L.C., Burchial K.J. The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas. Pain. 38:1989;333-338.
13. Chabal C., Jacobson L., Mariano A., Chaney E., Britell C.W. The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Anesthesiology. 76:1992;513-517.
14. Chaplan S.R., Bach F.W., Shafer S.L., Yaksh T.L. Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats. Anesthesiology. 83:1995;775-785.
15. Chapman V., Ng J., Dickenson A.H. A novel spinal action of mexiletine in spinal somatosensory transmission of nerve injured rats. Pain. 77:1998;289-296.
16. Chong S.F., Bretscher M.E., Mailliard J.A., Tschetter L.K., Kimmel D.W., Hatfield A.K., Loprinz C.L. Pilot study evaluating local anesthetics administered systemically for treatment of pain in patients with advanced cancer. J Pain Sympt Manage. 13:1997;112-117.
17. Chouu-Tan F.Y., Tuel S.M., Johnson J.C. Effect of mexiletine on spinal cord injury dysesthetic pain. Am J Phys Med Rehab. 75:1996;84-87.
18. Cummins T.R., Waxman S.G. Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury. J Neurosci. 17:1997;3503-3514.
19. Davis R.W. Successful treatment for phantom limb pain. Orthopedics. 16:1993;691-695.
20. Dejgard A., Petersen P., Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet. 2:1988;9-11.
21. Devor M. Neuropathic pain and injured nerve: peripheral mechanisms. Br Med Bull. 47:1991;619-630.
22. Devor M., Wall P.D. Cross-excitation in dorsal root ganglia of nerve-injured and intact rats. J Neurophysiol. 64:1990;1733-1746.
23. Devor M., Wall P.D., Catalan N. Systemic lidocaine silences ectopic neuroma and DRG discharges without blocking nerve conduction. Pain. 48:1992;261-268.
24. Devulder J.E., Ghys L., Dhondt W., Rolly G. Neuropathic pain in a cancer patient responding to subcutaneously administered lignocaine. Clin J Pain. 9:1993;220-223.
25. Edmondson E.A., Simpson R.K. Jr., Stubler D.K., Beric A. Systemic lidocaine therapy for poststroke pain. South Med J. 86:1993;1093-1096.
26. Edwards W.T., Habib F., Burney R.G., Begin G. Intravenous lidocaine in the management of various chronic pain states. A review of 211 cases. Reg Anesth. 10:1985;1-6.
27. Ferrante F.M., Paggiol J., Cherukuri S., Arthur G.R. The analgesic response to intravenous lidocaine in the treatment of neuropathic pain. Anesth Analg. 82:1996;91-97.
28. Galer B.S., Miller K.V., Rowbotham M.C. Responses to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury. Neurology. 43:1993;1233-1235.
29. Galer B.S., Harle J., Rowbotham M.C. Response to intravenous lidocaine infusion predicts subsequent response to oral mexiletine: a prospective study. J Pain Sympt Manage. 12:1996;161-167.
30. Gracely R.H., Lynch S.A., Bennett G.J. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain. 51:1992;175-194.
31. Hunter J.C., Gogas K.R., Hedley L.R., Jacobson L.O., Kassotakis L., Thompson J., Fontana D. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol. 324:1997;153-160.
32. Jarvis B., Coukell A.J. Mexiletine: a review of its therapeutic use in painful diabetic neuropathy. Drugs. 56:1998;691-707.
33. Jasmin L., Kohan L., Franssen M., Janni G., Goff J.R. The cold plate as a test of nociceptive behaviors: description and application to the study of chronic neuropathic and inflammatory pain models. Pain. 75:1998;367-382.
34. Jett M.F., McGuirk J., Waligora D., Hunter J.C. The effect of mexiletine, desipramine and fluoxetine in rat models involving central sensitization. Pain. 69:1997;161-169.
35. Kajander K.C., Wakisaka S., Bennett G.J. Spontaneous discharge originates in the dorsal root ganglion at the onset of a painful peripheral neuropathy in the rat. Neurosci Lett. 138:1992;225-228.
36. Kastrup J., Petersen P., Dejgard A., Angelo H.R., Hilsted J. Intravenous lidocaine infusion - a new treatment of chronic painful diabetic neuropathy. Pain. 28:1987;69-75.
37. Kim S.H., Chung J.M. An experimental model of peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
38. Lee D.H., Liu X., Kim H.T., Chung K., Chung J.M. Receptor subtype mediating the adrenergic sensitivity of pain behavior and ectopic discharges in neuropathic Lewis rats. J Neurophysiol. 81:1999;2226-2233.
39. Mao J., Price D.D., Mayer D.J., Lu J., Hayes R.L. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res. 576:1992;254-262.
40. Mao J., Price D.D., Mayer D.J. Mechanisms of hyperalgesia and opiate tolerance: a current view of their possible interactions. Pain. 62:1995;259-274.
41. Marchettini P., Lacerenza M., Marangoni C., Pellegata G., Sotgiu M.L., Smirne S. Lidocaine test in neuralgia. Pain. 48:1992;377-382.
42. Nordin M., Nystrom B., Wallin U., Hagbarth K.E. Ectopic sensory discharges and paresthesia in patients with disorders of peripheral nerves, dorsal roots and dorsal column. Pain. 20:1984;231-245.
43. Nystrom B., Hagbarth K.E. Microelectrode recordings from transected nerves in amputees with phantom limb pain. Neurosci Lett. 27:1981;211-216.
44. Omana-Zapata I., Khabbaz M.A., Hunter J.C., Bley K.R. QX-314 inhibits ectopic nerve activity associated with neuropathic pain. Brain Res. 771:1997;228-237.
45. Porreca F., Lai J., Bian D., Wegert S., Ossipov M.H., Eglen R.M., Kassotakis L., Novakovic S., Rabert D., Sangggameswaran L., Hunter J.C. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat model of chronic pain. Proc Natl Acad Sci USA. 96:1999;7640-7644.
46. Quashoff S., Grosskreutz J., Schroder J.M., Schneider U., Grafe P. Calcium potentials and tetrodotoxin-resistant sodium potentials in unmyelinated c-fibers of biopsied human sural nerve. Neuroscience. 69:1995;955-965.
47. Rowbotham M., Reisner-Keller L.A., Fields H.L. Both intravenous lidocaine and morphine reduced the pain of postherpetic neuralgia. Neurology. 41:1991;1024-1028.
48. Rowbotham M.C., Davies P.S., Fields H.L. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol. 37:1995;246-253.
49. Roy M.L., Narahashi T. Differential properties of tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels in rat dorsal root ganglion neurons. J Neurosci. 12:1992;2104-2111.
50. Schnider T.W., Gaeta R., Minto C.F.B., Gregg K.M., Shafer S.L. Derivation and cross-validation of pharmacokinetic parameters for computer-controlled infusion of lidocaine in pain therapy. Anesthesiology. 84:1996;1045-1050.
51. Seltzer Z., Cohn S., Ginzgurg R., Berlin B. Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharges. Pain. 45:1991;69-75.
52. Sinnott C.J., Garfield J.M., Strichartz G.R. Differential efficacy of intravenous lidocaine in alleviating ipsilateral versus contralateral neuropathic pain in the rat. Pain. 80:1999;521-531.
53. Sotgiu M.L., Biella G., Castagna A., Lacerenza M., Marchettini P. Different time-courses of IV lidocaine effect on ganglionic and spinal units in neuropathic rats. NeuroReport. 5:1994;873-876.
54. Stebbing M.J., Eschenfelder S., Habler H.J., Acosta M.C., Janig W., McLachlan E.M. Changes in the action potential in sensory neurons after axotomy in vivo. NeuroReport. 10:1999;201-206.
55. Strichartz G.R. Protracted relief of experimental neuropathic pain by systemic local anesthetics. Anesthesiology. 83:1995;654-655.
56. Tanelian D., Brose W. Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbamazepine, and mexiletine. Anesthesiology. 74:1991;949-951.
57. Tanelian D., MacIver M.B. Analgesic concentrations of lidocaine suppress tonic A-delta and C fiber discharges produced by acute injury. Anesthesiology. 74:1991;934-936.
58. Thomas P.K. Clinical features and differential diagnosis of peripheral neuropathy. Dyck P.J., Thomas P.K., Lambert E.H., Bunge R. Peripheral neuropathy. 2:1984;1169-1190 W.B. Saunders, Philadelphia, PA.
59. Wall P.D., Gutnick M. Properties of afferent nerve impulses originating from a neuroma. Nature. 248:1974;740-743.
60. Wallace M.S., Dyck J.B., Rossi S.S., Yaksh T.L. Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain. 66:1996;69-77.
61. Wallace M.S., Laitin S., Licht D., Yaksh T.L. Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effects on acute sensory thresholds and capsaicin-evoked hyperpathia. Anesthesiology. 86:1997;1261-1272.
62. Waxman S.G., Cummins T.R., Dib-Hajj S., Fjell J., Black J.A. Sodium channels, excitability of primary sensory neurons, and the molecular basis of pain. Muscle Nerve. September:1999;1177-1187.
63. Waxman S.G., Dib-Hajj S., Cummins T.R., Black J.A. Sodium channels and pain. Proc Natl Acad Sci USA. 96:1999;7635-7639.
64. Woolf C.J., Wiesenfeld-Hallin Z. The systemic administration of local anesthetics produces a selective depression of C-afferent fiber evoked activity in the spinal cord. Pain. 23:1985;361-374.
65. Zhang J.M., Song X.J., LaMotte R.H. An in vitro study of ectopic discharge generation and adrenergic sensitivity in the intact, nerve-injured rat dorsal root ganglion. Pain. 72:1997;51-57.